IL-6 blockade for myocardial infarction

Int J Cardiol. 2018 Nov 15:271:19-20. doi: 10.1016/j.ijcard.2018.06.068. Epub 2018 Jun 21.

Authors

Atsuhiko Iuchi¹, Hiroshi Harada¹, Toshio Tanaka²

Affiliations

¹ Department of Cardiology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, Osaka 583-8588, Japan.
² Department of Cardiology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, Osaka 583-8588, Japan. Electronic address: ttanak@ra.opho.jp.

PMID: 30482454
DOI: 10.1016/j.ijcard.2018.06.068

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Chemokine CCL4*
Chemokine CXCL10
Humans
Interleukin-6
Myocardial Infarction
Non-ST Elevated Myocardial Infarction
Receptors, Interleukin-6*

Substances

Antibodies, Monoclonal, Humanized
Chemokine CCL4
Chemokine CXCL10
Interleukin-6
Receptors, Interleukin-6
tocilizumab